Skip to Content

134 Results Found

  • Article
  • Open Access
7 Citations
2,474 Views
14 Pages

Surface Modification of GdMn2O5 for Catalytic Oxidation of Benzene via a Mild A-Site Sacrificial Strategy

  • Ju Gao,
  • Xu Dong,
  • Zhenguo Li,
  • Yuankai Shao,
  • Xiaoning Ren,
  • Kaixiang Li and
  • Yiren Lu

18 October 2022

Thermal catalytic oxidation technology is an effective way to eliminate refractory volatile organic pollutants, such as Benzene. Nevertheless, a high reaction temperature is usually an obstacle to practical application. Here, GdMn2O5 mullite (GMO-H)...

(This article belongs to the Section Environmental Catalysis)
  • Review
  • Open Access
20 Citations
18,335 Views
15 Pages

New Insights and Future Perspectives of APRIL in IgA Nephropathy

  • Masahiro Muto,
  • Hitoshi Suzuki and
  • Yusuke Suzuki

26 September 2024

IgA nephropathy (IgAN) is characterized by immune-mediated glomerulonephritis, with the accumulation of galactose-deficient IgA1 (Gd-IgA1) in the glomeruli and increased levels of circulating Gd-IgA1 and Gd-IgA1-containing immune complexes. An incomp...

(This article belongs to the Special Issue Molecular Pathology, Diagnostics and Therapeutics of Nephropathy 3.0)
  • Article
  • Open Access
14 Citations
3,795 Views
15 Pages

Effects of Gestational Diabetes in Cognitive Behavior, Oxidative Stress and Metabolism on the Second-Generation Off-Spring of Rats

  • Maribel Huerta-Cervantes,
  • Donovan J. Peña-Montes,
  • Miguel Ángel López-Vázquez,
  • Rocío Montoya-Pérez,
  • Christian Cortés-Rojo,
  • María Esther Olvera-Cortés and
  • Alfredo Saavedra-Molina

8 May 2021

Gestational diabetes (GD) has a negative impact on neurodevelopment, resulting in cognitive and neurological deficiencies. Oxidative stress (OS) has been reported in the brain of the first-generation offspring of GD rats. OS has been strongly associa...

(This article belongs to the Section Nutrition and Metabolism)
  • Article
  • Open Access
8 Citations
3,982 Views
16 Pages

Y-Box Binding Protein 1 Expression in Trophoblast Cells Promotes Fetal and Placental Development

  • Nicole Meyer,
  • Anne Schumacher,
  • Urs Coenen,
  • Katja Woidacki,
  • Hannah Schmidt,
  • Jonathan A. Lindquist,
  • Peter R. Mertens and
  • Ana C. Zenclussen

22 August 2020

Y-box binding protein 1 (YB-1) is pivotal for the regulation of cancerogenesis and inflammation. However, its involvement in pregnancy processes such as fetal and placental development remains to be elucidated. We studied Ybx1 (YB-1)+/− heteroz...

  • Article
  • Open Access
14 Citations
4,691 Views
12 Pages

Effects of Microencapsulated Methionine on Milk Production and Manure Nitrogen Excretions of Lactating Dairy Cows

  • Layla King,
  • Janaka Wickramasinghe,
  • Brooke Dooley,
  • Carrie McCarthy,
  • Emily Branstad,
  • Ester Grilli,
  • Lance Baumgard and
  • Ranga Appuhamy

14 December 2021

The study objective was to determine the effects of rumen-protected methionine (Met) by microencapsulation (RPM) on amino acid (AA) supply to the udder, milk production, and manure nitrogen (N) losses of dairy cows. A corn and soybean-based diet defi...

(This article belongs to the Topic Development of Agricultural and Food By-Product Resources and Animal Production to Achieve Food Sustainability)
  • Article
  • Open Access
2 Citations
3,853 Views
8 Pages

Vitamin D Levels in Patients with Active and Remission Graves’ Disease

  • Natapon Rattanamusik,
  • Suriyon Uitrakul and
  • Atchara Charoenpiriya

Background: The association between Graves’ disease (GD) and serum vitamin D levels has been studied for decades although the results were controversial. Moreover, the difference in vitamin D levels between the different stages of GD is not wel...

(This article belongs to the Section Endocrinology and Metabolic Disorders)
  • Case Report
  • Open Access
6 Citations
4,956 Views
8 Pages

Pediatric Gaucher Disease Presenting with Massive Splenomegaly and Hepatic Gaucheroma

  • Gianluca Bossù,
  • Laura Pedretti,
  • Lorenzo Bertolini and
  • Susanna Esposito

Gaucher Disease (GD) is a condition resulting from an autosomal recessive inheritance pattern, characterized by a deficiency of the lysosomal enzyme beta-glucocerebrosidase. This leads to the accumulation of glucocerebroside and other glycolipids in...

(This article belongs to the Collection Development of Medicines for Paediatric and Rare Diseases)
  • Feature Paper
  • Review
  • Open Access
3 Citations
3,424 Views
12 Pages

The Complexities of Diagnosis with Co-Existing Gaucher Disease and Hemato-Oncology—A Case Report and Review of the Literature

  • Paulina Sudul,
  • Beata Piatkowska-Jakubas,
  • Lukasz Pawlinski,
  • Krystyna Galazka,
  • Tomasz Sacha and
  • Beata Kiec-Wilk

25 August 2023

Hematological abnormalities are the most common early symptoms of Gaucher disease (GD), with an increased risk of hematopoietic system malignancies reported in patients with GD. GD may be associated with monoclonal and polyclonal gammopathies; howeve...

(This article belongs to the Section Clinical Neurology)
  • Article
  • Open Access
10 Citations
6,601 Views
18 Pages

Deficiency of Glucocerebrosidase Activity beyond Gaucher Disease: PSAP and LIMP-2 Dysfunctions

  • Eleonora Pavan,
  • Paolo Peruzzo,
  • Silvia Cattarossi,
  • Natascha Bergamin,
  • Andrea Bordugo,
  • Annalisa Sechi,
  • Maurizio Scarpa,
  • Jessica Biasizzo,
  • Fabiana Colucci and
  • Andrea Dardis

Glucocerebrosidase (GCase) is a lysosomal enzyme that catalyzes the breakdown of glucosylceramide in the presence of its activator saposin C (SapC). SapC arises from the proteolytical cleavage of prosaposin (encoded by PSAP gene), which gives rise to...

(This article belongs to the Collection Feature Papers in “Molecular Biology”)
  • Article
  • Open Access
19 Citations
5,144 Views
9 Pages

Galactose-Deficient IgA1 as a Candidate Urinary Marker of IgA Nephropathy

  • Yusuke Fukao,
  • Hitoshi Suzuki,
  • Jin Sug Kim,
  • Kyung Hwan Jeong,
  • Yuko Makita,
  • Toshiki Kano,
  • Yoshihito Nihei,
  • Maiko Nakayama,
  • Mingfeng Lee and
  • Yusuke Suzuki
  • + 3 authors

2 June 2022

In patients with IgA nephropathy (IgAN), circulatory IgA1 and IgA1 in the mesangial deposits contain galactose-deficient IgA1 (Gd-IgA1). Some of the Gd-IgA1 from the glomerular deposits is excreted in the urine and thus urinary Gd-IgA1 may represent...

(This article belongs to the Special Issue New Insights into the Pathogenesis and Therapies of IgA Nephropathy)
  • Review
  • Open Access
30 Citations
8,226 Views
15 Pages

Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development

  • Marzena Wątek,
  • Ewelina Piktel,
  • Tomasz Wollny,
  • Bonita Durnaś,
  • Krzysztof Fiedoruk,
  • Ewa Lech-Marańda and
  • Robert Bucki

15 February 2019

There is a rising number of evidence indicating the increased risk of cancer development in association with congenital metabolic errors. Although these diseases represent disorders of individual genes, they lead to the disruption of metabolic pathwa...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
36 Citations
5,128 Views
16 Pages

C5a Activates a Pro-Inflammatory Gene Expression Profile in Human Gaucher iPSC-Derived Macrophages

  • Jacquelyn C. Serfecz,
  • Afsoon Saadin,
  • Clayton P. Santiago,
  • Yuji Zhang,
  • Søren M. Bentzen,
  • Stefanie N. Vogel and
  • Ricardo A. Feldman

14 September 2021

Gaucher disease (GD) is an autosomal recessive disorder caused by bi-allelic GBA1 mutations that reduce the activity of the lysosomal enzyme β-glucocerebrosidase (GCase). GCase catalyzes the conversion of glucosylceramide (GluCer), a ubiquitous glyco...

(This article belongs to the Special Issue Pathophysiology, Molecular Mechanism and Therapeutic Strategies of Lysosomal Storage Disorders (LSD))
  • Review
  • Open Access
22 Citations
18,579 Views
13 Pages

An Overview of Gaucher Disease

  • Daniela Anahí Méndez-Cobián,
  • Sandra Guzmán-Silahua,
  • Diana García-Hernández,
  • Julian Conde-Sánchez,
  • Yaocihuatl Castañeda-Borrayo,
  • Kylee Louise Duey,
  • Maria G. Zavala-Cerna,
  • Benjamín Rubio-Jurado and
  • Arnulfo Hernán Nava-Zavala

17 December 2024

Background: Gaucher disease (GD) is a rare autosomal recessive disorder caused by mutations in the GBA1 gene that lead to a deficiency in the glucocerebrosidase gene. This deficiency results in the accumulation of glucocerebrosides in macrophages, pr...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Review
  • Open Access
28 Citations
6,493 Views
11 Pages

Neuropathological Features of Gaucher Disease and Gaucher Disease with Parkinsonism

  • Makaila L. Furderer,
  • Ellen Hertz,
  • Grisel J. Lopez and
  • Ellen Sidransky

Deficient acid β-glucocerebrosidase activity due to biallelic mutations in GBA1 results in Gaucher disease (GD). Patients with this lysosomal storage disorder exhibit a wide range of associated manifestations, spanning from virtually asymptomati...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Article
  • Open Access
9 Citations
5,396 Views
11 Pages

Insights into the Value of Lyso-Gb1 as a Predictive Biomarker in Treatment-Naïve Patients with Gaucher Disease Type 1 in the LYSO-PROOF Study

  • Filipa Curado,
  • Sabine Rösner,
  • Susanne Zielke,
  • Gina Westphal,
  • Ulrike Grittner,
  • Volha Skrahina,
  • Mohammed Alasel,
  • Ahmad Mehmood Malik,
  • Christian Beetz and
  • Arndt Rolfs
  • + 15 authors

30 August 2023

Gaucher disease (GD) is a rare autosomal recessive disorder arising from bi-allelic variants in the GBA1 gene, encoding glucocerebrosidase. Deficiency of this enzyme leads to progressive accumulation of the sphingolipid glucosylsphingosine (lyso-Gb1)...

(This article belongs to the Section Pathology and Molecular Diagnostics)
  • Article
  • Open Access
44 Citations
5,411 Views
20 Pages

Gestational Diabetes Triggers Oxidative Stress in Hippocampus and Cerebral Cortex and Cognitive Behavior Modifications in Rat Offspring: Age- and Sex-Dependent Effects

  • Maribel Huerta-Cervantes,
  • Donovan J. Peña-Montes,
  • Rocío Montoya-Pérez,
  • Xóchitl Trujillo,
  • Miguel Huerta,
  • Miguel Ángel López-Vázquez,
  • María Esther Olvera-Cortés and
  • Alfredo Saavedra-Molina

31 January 2020

Gestational diabetes (GD) has been linked with an increased risk of developing metabolic disorders and behavioral abnormalities in the offspring. Oxidative stress is strongly associated with neurodegeneration and cognitive disruption. In the offsprin...

  • Article
  • Open Access
2 Citations
2,275 Views
9 Pages

Effects of GBA1 Variants and Prenatal Exposition on the Glucosylsphingosine (Lyso-Gb1) Levels in Gaucher Disease Carriers

  • Paulina Szymańska-Rożek,
  • Patryk Lipiński,
  • Grazina Kleinotiene,
  • Paweł Dubiela and
  • Anna Tylki-Szymańska

8 November 2024

Gaucher disease (GD) is a lysosomal lipid storage disorder caused by β-glucocerebrosidase (encoded by GBA1 gene) activity deficiency, resulting in the accumulation of glucosylceramide (Gb1) and its deacylated metabolite glucosylsphingosine (lyso...

(This article belongs to the Special Issue Gaucher Disease: From Molecular Mechanisms to Treatments)
  • Article
  • Open Access
1 Citations
473 Views
10 Pages

Unraveling the Impact of Aging on the Structural, Magnetic, and Superconducting Properties of 2G HTS Tapes

  • Paweł Pęczkowski,
  • Jarosław Piętosa,
  • Piotr Zachariasz,
  • Paweł Gąsior,
  • Ryszard Zalecki,
  • Jan Marek Michalik,
  • Łukasz Gondek and
  • Anna Krztoń-Maziopa

10 June 2026

Second-generation high-temperature superconducting tapes (2G HTS; SuperPower Inc., Glenville, NY, USA) based on GdBCO (GdBa2Cu3O7−δ, where δ denotes oxygen deficiency) were aged at −26.4 °C, +2 °C, and room temperature...

(This article belongs to the Section Electronic Materials)
  • Article
  • Open Access
22 Citations
5,430 Views
16 Pages

Immunoglobulin Abnormalities in Gaucher Disease: an Analysis of 278 Patients Included in the French Gaucher Disease Registry

  • Yann Nguyen,
  • Jérôme Stirnemann,
  • Florent Lautredoux,
  • Bérengère Cador,
  • Monia Bengherbia,
  • Karima Yousfi,
  • Dalil Hamroun,
  • Leonardo Astudillo,
  • Thierry Billette de Villemeur and
  • on behalf of the French Evaluation of Gaucher Disease Treatment Committee
  • + 13 authors

13 February 2020

Gaucher disease (GD) is a rare lysosomal autosomal-recessive disorder due to deficiency of glucocerebrosidase; polyclonal gammopathy (PG) and/or monoclonal gammopathy (MG) can occur in this disease. We aimed to describe these immunoglobulin abnormali...

(This article belongs to the Special Issue Pathophysiology, Molecular Mechanism and Therapeutic Strategies of Lysosomal Storage Disorders (LSD))
  • Article
  • Open Access
1 Citations
584 Views
15 Pages

24 June 2026

Background: Vitamin D deficiency is highly prevalent in older adults and has been increasingly recognised as a potential contributor to cognitive decline, depressive symptomatology, and functional impairment. However, the clinical significance of spe...

(This article belongs to the Section Micronutrients and Human Health)
  • Review
  • Open Access
85 Citations
16,300 Views
30 Pages

Glucocerebrosidase: Functions in and Beyond the Lysosome

  • Daphne E.C. Boer,
  • Jeroen van Smeden,
  • Joke A. Bouwstra and
  • Johannes M.F.G Aerts

Glucocerebrosidase (GCase) is a retaining β-glucosidase with acid pH optimum metabolizing the glycosphingolipid glucosylceramide (GlcCer) to ceramide and glucose. Inherited deficiency of GCase causes the lysosomal storage disorder named Gaucher...

(This article belongs to the Special Issue Lysosomal Storage Disorders: Causes, Symptoms, Diagnosis, and Treatment)
  • Article
  • Open Access
10 Citations
3,200 Views
16 Pages

Exploring the Pathophysiologic Cascade Leading to Osteoclastogenic Activation in Gaucher Disease Monocytes Generated via CRISPR/Cas9 Technology

  • Maximiliano Emanuel Ormazabal,
  • Eleonora Pavan,
  • Emilio Vaena,
  • Dania Ferino,
  • Jessica Biasizzo,
  • Juan Marcos Mucci,
  • Fabrizio Serra,
  • Adriana Cifù,
  • Maurizio Scarpa and
  • Andrea Elena Dardis
  • + 1 author

Gaucher disease (GD) is caused by biallelic pathogenic variants in the acid β-glucosidase gene (GBA1), leading to a deficiency in the β-glucocerebrosidase (GCase) enzyme activity resulting in the intracellular accumulation of sphingolipids....

(This article belongs to the Collection Feature Papers in “Molecular Biology”)
  • Communication
  • Open Access
6 Citations
3,037 Views
10 Pages

Long- and Short-Term Glucosphingosine (lyso-Gb1) Dynamics in Gaucher Patients Undergoing Enzyme Replacement Therapy

  • Pawel Dubiela,
  • Paulina Szymanska-Rozek,
  • Piotr Hasinski,
  • Patryk Lipinski,
  • Grazina Kleinotiene,
  • Dorota Giersz and
  • Anna Tylki-Szymanska

12 July 2024

Background: Gaucher disease (GD) is a lysosomal storage disorder caused by mutations in the GBA1 gene, leading to β-glucocerebrosidase deficiency and glucosylceramide accumulation. Methods: We analyzed short- and long-term dynamics of lyso-gluco...

(This article belongs to the Section Molecular Biomarkers)
  • Review
  • Open Access
2 Citations
1 Views
6 Pages

Molecular Basis and Clinical Management of Gaucher Disease

  • Maja Di Rocco,
  • Andrea Loggini and
  • Pierluigi Russo

Gaucher disease (GD) type I is an autosomal recessive disease caused by a genetic deficiency of lysosomal β-glucocerebrosidase that leads to accumulation of undergraded substrate glucocerebroside and other glycolipids, thus causing damage in differen...

  • Article
  • Open Access
25 Citations
4,634 Views
21 Pages

Identification of a Reliable Biomarker Profile for the Diagnosis of Gaucher Disease Type 1 Patients Using a Mass Spectrometry-Based Metabolomic Approach

  • Iskren Menkovic,
  • Michel Boutin,
  • Abdulfatah Alayoubi,
  • François E. Mercier,
  • Georges-Étienne Rivard and
  • Christiane Auray-Blais

23 October 2020

Gaucher disease (GD) is a rare autosomal recessive multisystemic lysosomal storage disorder presenting a marked phenotypic and genotypic variability. GD is caused by a deficiency in the glucocerebrosidase enzyme. The diagnosis of GD remains challengi...

(This article belongs to the Special Issue Biomarkers in Rare Diseases)
  • Article
  • Open Access
9 Citations
6,595 Views
24 Pages

Intolerance to dairy products resulting from the abnormal digestion of milk sugar (lactose) is a common cause of human gastrointestinal disorders. The aim of this study was to show that the -13910 C>T LCT gene polymorphism, together with genotypes...

(This article belongs to the Section Molecular Pathology, Diagnostics, and Therapeutics)
  • Feature Paper
  • Article
  • Open Access
12 Citations
3,948 Views
10 Pages

iPSC-Derived Gaucher Macrophages Display Growth Impairment and Activation of Inflammation-Related Cell Death

  • Daria Messelodi,
  • Salvatore Nicola Bertuccio,
  • Valentina Indio,
  • Silvia Strocchi,
  • Alberto Taddia,
  • Salvatore Serravalle,
  • Jessica Bandini,
  • Annalisa Astolfi and
  • Andrea Pession

21 October 2021

Gaucher disease is a lysosomal storage disorder characterized by β-glucosidase enzyme deficiency and substrate accumulation, especially in cells of the reticuloendothelial system. Typical features of the disease are the unrestrained activation of inf...

(This article belongs to the Special Issue Induced Pluripotent Stem Cells (IPSC) as a Disease Modeling and Drug Development Platform)
  • Review
  • Open Access
45 Citations
13,207 Views
12 Pages

New Treatment Strategies for IgA Nephropathy: Targeting Plasma Cells as the Main Source of Pathogenic Antibodies

  • Dita Maixnerova,
  • Delphine El Mehdi,
  • Dana V. Rizk,
  • Hong Zhang and
  • Vladimir Tesar

16 May 2022

Immunoglobulin A nephropathy (IgAN) is a rare autoimmune disorder and the leading cause of biopsy-reported glomerulonephritis (GN) worldwide. Disease progression is driven by the formation and deposition of immune complexes composed of galactose-defi...

(This article belongs to the Special Issue New Insights into the Pathogenesis and Therapies of IgA Nephropathy)
  • Article
  • Open Access
1,574 Views
12 Pages

Study of Adult and Pediatric Spanish Patients with Cryptogenic Splenomegaly and Splenectomy

  • Marta Morado Arias,
  • Jesús Villarrubia Espinosa,
  • Isidro Vitoria Miñana,
  • Enrique Calderón Sandubete,
  • Víctor Quintero and
  • Miguel Ángel Torralba-Cabeza

30 March 2025

Introduction: The differential diagnosis of splenomegaly is a complex process that encompasses a wide variety of diseases. Moreover, it is not always standardized and lacks a definitive consensus on which tests should be performed and in what order....

(This article belongs to the Section Rare Syndrome)
  • Review
  • Open Access
34 Citations
5,734 Views
9 Pages

21 January 2022

We have endeavored in this review to summarize our findings, which point to a systemic deficiency of ganglioside GM1 in Parkinson’s disease (PD) tissues. These include neuronal tissues well known to be involved in PD, such as substantia nigra o...

(This article belongs to the Section Lipids)
  • Article
  • Open Access
21 Citations
4,909 Views
11 Pages

Clinical Relevance of Serum Galactose Deficient IgA1 in Patients with IgA Nephropathy

  • Jin Sug Kim,
  • Hyeon Seok Hwang,
  • Sang Ho Lee,
  • Yang Gyun Kim,
  • Ju-Young Moon,
  • Ji Yoon Kong and
  • Kyung Hwan Jeong

4 November 2020

New biomarkers of IgA nephropathy (IgAN) are needed for non-invasive diagnosis and appropriate treatment. There is emerging evidence that galactose deficient IgA1 (Gd-IgA1) is a pivotal molecule in the pathogenesis of IgAN. However, few studies have...

(This article belongs to the Special Issue Pathogenesis, Clinical Diagnosis, Treatments and Complications of Glomerular Diseases)
  • Review
  • Open Access
766 Citations
88,332 Views
30 Pages

A Review of Gaucher Disease Pathophysiology, Clinical Presentation and Treatments

  • Jérôme Stirnemann,
  • Nadia Belmatoug,
  • Fabrice Camou,
  • Christine Serratrice,
  • Roseline Froissart,
  • Catherine Caillaud,
  • Thierry Levade,
  • Leonardo Astudillo,
  • Jacques Serratrice and
  • Marc G. Berger
  • + 3 authors

17 February 2017

Gaucher disease (GD, ORPHA355) is a rare, autosomal recessive genetic disorder. It is caused by a deficiency of the lysosomal enzyme, glucocerebrosidase, which leads to an accumulation of its substrate, glucosylceramide, in macrophages. In the genera...

(This article belongs to the Special Issue Lysosomal Storage Disorders: Novel Concepts, Therapeutic Aspects and Beyond)
  • Case Report
  • Open Access
1 Citations
2,305 Views
8 Pages

Pediatric Gaucher Disease Type 3 Presenting with Oculomotor Apraxia: A Case Report

  • Margherita Di Costanzo,
  • Nicoletta de Paulis,
  • Giuseppe Cannalire,
  • Nicola Morelli and
  • Giacomo Biasucci

9 August 2024

We report on a 4-year-old boy affected by Gaucher disease (GD) type 3, who presented with splenomegaly and a history of oculomotor apraxia. GD is a rare lysosomal storage disorder caused by glucocerebrosidase deficiency with multi-organ involvement....

(This article belongs to the Section Pediatric Neurology & Neurodevelopmental Disorders)
  • Article
  • Open Access
1 Citations
1,309 Views
12 Pages

Objectives: The aim of this study was to find correlations between vitamin D deficiency and thyroid autoimmune pathology in a group of patients from Dobrogea, a non-endemic geographical area, with a high degree of sunshine. An important factor in mai...

(This article belongs to the Section Immunology & Rheumatology)
  • Article
  • Open Access
16 Citations
7,107 Views
15 Pages

Osteocyte Alterations Induce Osteoclastogenesis in an In Vitro Model of Gaucher Disease

  • Constanza Bondar,
  • Maximiliano Ormazabal,
  • Andrea Crivaro,
  • Malena Ferreyra-Compagnucci,
  • María Victoria Delpino,
  • Paula Adriana Rozenfeld and
  • Juan Marcos Mucci

Gaucher disease (GD) is caused by mutations in the glucosylceramidase β (GBA 1) gene that confer a deficient level of activity of glucocerebrosidase (GCase). This deficiency leads to the accumulation of the glycolipid glucocerebroside in the lysosome...

(This article belongs to the Special Issue Lysosomal Storage Disorders: Novel Concepts, Therapeutic Aspects and Beyond)
  • Article
  • Open Access
10 Citations
3,146 Views
11 Pages

Associations between Biomarkers of Complement Activation, Galactose-Deficient IgA1 Antibody and the Updated Oxford Pathology Classification of IgA Nephropathy

  • Yun-Ting Juan,
  • Wen-Chih Chiang,
  • Wei-Chou Lin,
  • Cheng-Wen Yang,
  • San-Fang Chou,
  • Ruo-Wei Hung and
  • Yen-Ling Chiu

21 July 2022

Our prior study indicates a close relationship between alternative complement pathway activation, galactose-deficient IgA1 (Gd-IgA1) concentration and clinical severity of IgA nephropathy (IgAN). Nonetheless, the relationship between complement facto...

(This article belongs to the Section Nephrology & Urology)
  • Review
  • Open Access
35 Citations
12,831 Views
12 Pages

The Role of Vitamin D in Autoimmune Thyroid Diseases: A Narrative Review

  • Agata Czarnywojtek,
  • Ewa Florek,
  • Krzysztof Pietrończyk,
  • Nadia Sawicka-Gutaj,
  • Marek Ruchała,
  • Ohad Ronen,
  • Iain J. Nixon,
  • Ashok R. Shaha,
  • Juan Pablo Rodrigo and
  • Alfio Ferlito
  • + 3 authors

11 February 2023

Vitamin D (VitD) deficiency has garnered significant attention in contemporary medical research. Although the canonical biological activity of VitD manifests itself mainly in the regulation of calcium-phosphorus metabolism, recent studies show that,...

(This article belongs to the Topic Public Health and Healthcare in the Context of Big Data)
  • Article
  • Open Access
6 Citations
3,094 Views
14 Pages

The Expression and Secretion Profile of TRAP5 Isoforms in Gaucher Disease

  • Margarita M. Ivanova,
  • Julia Dao,
  • Neala Loynab,
  • Sohailla Noor,
  • Neil Kasaci,
  • Andrew Friedman and
  • Ozlem Goker-Alpan

20 April 2024

Background: Gaucher disease (GD) is caused by glucocerebrosidase (GCase) enzyme deficiency, leading to glycosylceramide (Gb-1) and glucosylsphingosine (Lyso-Gb-1) accumulation. The pathological hallmark for GD is an accumulation of large macrophages...

(This article belongs to the Topic Osteoimmunology and Bone Biology)
  • Review
  • Open Access
195 Citations
21,653 Views
14 Pages

Meta-Analysis of the Association between Vitamin D and Autoimmune Thyroid Disease

  • Jiying Wang,
  • Shishi Lv,
  • Guo Chen,
  • Chenlin Gao,
  • Jianhua He,
  • Haihua Zhong and
  • Yong Xu

3 April 2015

Although emerging evidence suggests that low levels of vitamin D may contribute to the development of autoimmune disease, the relationship between vitamin D reduction and autoimmune thyroid disease (AITD), which includes Graves’ disease (GD) and Hash...

(This article belongs to the Special Issue Immune Regulation by Vitamin D)
  • Article
  • Open Access
20 Citations
5,521 Views
11 Pages

14 May 2020

Anaemia caused by iron deficiency has long been reported in dairy calves. This study investigated iron deficiency anaemia on UK dairy farms feeding whole milk and evaluated the effect of iron supplementation on the daily weight gain (DG) and haemoglo...

(This article belongs to the Section Cattle)
  • Article
  • Open Access
2 Citations
1,389 Views
13 Pages

Gaucher Disease—Correlation of Lyso-Gb1 with Haematology and Biochemical Parameters

  • Simona D’Amore,
  • Sneha Patel,
  • Juniebel Cooke and
  • Uma Ramaswami

7 November 2025

Background/Objectives: Gaucher disease (GD) is a lysosomal disorder caused by a deficiency of β-glucosidase. Disease-modifying therapies (DMTs) include enzyme replacement therapy (ERT) and substrate reduction therapy (SRT). Glucosylsphingosine (...

(This article belongs to the Section Endocrinology and Clinical Metabolic Research)
  • Article
  • Open Access
9 Citations
7,863 Views
14 Pages

Usual Protein Intake Amount and Sources of Nursing Home Residents with (Risk of) Malnutrition and Effects of an Individualized Nutritional Intervention: An enable Study

  • Johanna Seemer,
  • Dorothee Volkert,
  • Daniela Fleckenstein-Sußmann,
  • Stephanie Bader-Mittermaier,
  • Cornel Christian Sieber and
  • Eva Kiesswetter

24 June 2021

Nursing home (NH) residents with (risk of) malnutrition are at particular risk of low protein intake (PI). The aim of the present analysis was (1) to characterize usual PI (total amount/day (d) and meal, sources/d and meal) of NH residents with (risk...

(This article belongs to the Special Issue Nutritional Status of Older Adults)
  • Article
  • Open Access
19 Citations
4,484 Views
14 Pages

Deficiency of GD3 Synthase in Mice Resulting in the Attenuation of Bone Loss with Aging

  • Shoyoku Yo,
  • Kazunori Hamamura,
  • Yoshitaka Mishima,
  • Kosuke Hamajima,
  • Hironori Mori,
  • Koichi Furukawa,
  • Hisataka Kondo,
  • Kenjiro Tanaka,
  • Takuma Sato and
  • Akifumi Togari
  • + 2 authors

Gangliosides are widely expressed in almost all tissues and cells and are also considered to be essential in the development and maintenance of various organs and tissues. However, little is known about their roles in bone metabolism. In this study,...

(This article belongs to the Special Issue Gangliosides: Modes of Action and Cell Fates)
  • Article
  • Open Access
14 Citations
5,039 Views
16 Pages

Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells

  • Lucie Dupuis,
  • Margaux Chauvet,
  • Emmanuelle Bourdelier,
  • Michaël Dussiot,
  • Nadia Belmatoug,
  • Caroline Le Van Kim,
  • Arnaud Chêne and
  • Mélanie Franco

Gaucher disease (GD) is caused by glucocerebrosidase deficiency leading to the accumulation of sphingolipids in macrophages named “Gaucher’s Cells”. These cells are characterized by deregulated expression of cell surface markers, ab...

(This article belongs to the Special Issue Physiology of Red Cell Lineage: From Erythroblast Progenitors to Mature Red Blood Cell)
  • Review
  • Open Access
7 Citations
1,897 Views
16 Pages

10 February 2026

Gaucher disease (GD) is a lysosomal storage disorder caused by mutations in the glucocerebrosidase gene (GBA1), leading to acid β-glucosidase deficiency and the accumulation of glucosylceramide-derived glycosphingolipids. Its three phenotypes (n...

(This article belongs to the Special Issue Gaucher Disease: From Molecular Mechanisms to Treatments)
  • Review
  • Open Access
4 Citations
11,383 Views
20 Pages

Gaucher Disease in Internal Medicine and Dentistry

  • Michele Basilicata,
  • Giulia Marrone,
  • Manuela Di Lauro,
  • Eleonora Sargentini,
  • Vincenza Paolino,
  • Redan Hassan,
  • Giuseppe D’Amato,
  • Patrizio Bollero and
  • Annalisa Noce

22 March 2023

Gaucher disease (GD) is a lysosomal storage pathological condition, characterized by a genetic autosomal recessive transmission. The GD cause is the mutation of GBA1 gene, located on the chromosome 1 (1q21), that induces the deficiency of the lysosom...

(This article belongs to the Special Issue Oral Pathology and Medicine: Diagnosis and Therapy)
  • Article
  • Open Access
1 Citations
2,265 Views
10 Pages

Local Phase Segregation Induced by Ion Milling in 2:17-Type Sm-Co Based Magnets

  • Xin Song,
  • Yao Liu,
  • Wentao Jia,
  • Jian Li,
  • Xiaolian Liu,
  • Lizhong Zhao,
  • Tao Yuan and
  • Tianyu Ma

14 June 2023

Transmission electron microscopy (TEM) is indispensable to reveal the cellular nanostructure of the 2:17-type Sm-Co based magnets which act as the first choice for high-temperature magnet-associated devices. However, structural deficiencies could be...

(This article belongs to the Special Issue Structures and Magnetic Properties of Nanostructured Permanent Magnets)
  • Article
  • Open Access
187 Views
27 Pages

Lipidomic Profiling of Peripheral Extracellular Vesicles as a Potential Source of Biomarkers in Gaucher Disease

  • Joy Guingab-Cagmat,
  • Mariola J. Ferraro,
  • Timothy J. Garrett and
  • Gustavo H. B. Maegawa

13 October 2026

Extracellular vesicles (EVs) are small, membrane-enclosed nanovesicles released by cells and play an essential role in cellular communication. EVs contain condensed information about physiological/pathological states, serving as fingerprints and prov...

(This article belongs to the Section Cellular Metabolism)
  • Article
  • Open Access
1 Citations
2,293 Views
13 Pages

Novel Red Phosphor of Gd3+, Sm3+ co-Activated AgxGd((2−x)/3)−0.3−ySmyEu3+0.30☐(1−2x−2y)/3WO4 Scheelites for LED Lighting

  • Vladimir A. Morozov,
  • Bogdan I. Lazoryak,
  • Aleksandra A. Savina,
  • Elena G. Khaikina,
  • Ivan I. Leonidov,
  • Alexey V. Ishchenko and
  • Dina V. Deyneko

13 June 2023

Gd3+ and Sm3+ co-activation, the effect of cation substitutions and the creation of cation vacancies in the scheelite-type framework are investigated as factors influencing luminescence properties. AgxGd((2−x)/3)−0.3−ySmyEu3+0.3a...

(This article belongs to the Special Issue Advanced Materials for Optical and Luminescence Applications)
  • Article
  • Open Access
5 Citations
3,661 Views
14 Pages

A Brazilian Rare-Disease Center’s Experience with Glucosylsphingosine (lyso-Gb1) in Patients with Gaucher Disease: Exploring a Novel Correlation with IgG Levels in Plasma and a Biomarker Measurement in CSF

  • Matheus Vernet Machado Bressan Wilke,
  • Gabrielle Dineck Iop,
  • Larissa Faqueti,
  • Layzon Antonio Lemos da Silva,
  • Francyne Kubaski,
  • Fabiano O. Poswar,
  • Kristiane Michelin-Tirelli,
  • Dévora Randon,
  • Wyllians Vendramini Borelli and
  • Ida Vanessa D. Schwartz
  • + 1 author

Gaucher disease (GD, OMIM 230800) is one of the most common lysosomal disorders, being caused by the deficient activity of the enzyme acid β-glucocerebrosidase (Gcase). Three clinical forms of Gaucher’s disease (GD) are classified based on...

(This article belongs to the Special Issue Genetic and Metabolic Molecular Research of Lysosomal Storage Disease 3.0)

of 3